Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Marsh McLennan

Is Marsh & McLennan Stock Outperforming the S&P 500?

Marsh & McLennan has exceeded the broader S&P Index’s performance over the past year, but analysts remain cautious about the stock’s prospects.

Barchart

Marsh & McLennan Meets 80-Plus Relative Strength Rating Benchmark

Marsh & McLennan sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Marsh & McLennan Trying To Close In On Key Technical Measure

Marsh & McLennan shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Are Wall Street Analysts Bullish on Marsh & McLennan Stock?

Due to Marsh & McLennan’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

What You Need to Know Ahead of Marsh & McLennan's Earnings Release

Marsh & McLennan is scheduled to release its fiscal fourth-quarter earnings this month, and analysts project a double-digit profit growth.

Barchart

Marsh McLennan CIO's journey: From summer job to leading a team of 5,000

CIO Paul Beswick leads a team of more than 5,000 technologists and says a key area of focus is ensuring all four of Marsh McLennan business divisions share ideas.

Fortune

What Are Wall Street Analysts' Target Price for Marsh & McLennan Stock?

Despite Marsh & McLennan's underperformance relative to the broader market and its peers over the past year, Wall Street analysts are cautious about the stock's prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Insurer Breaks Out On Results, Rival Eyes Buy Point

Dow Jones insurer Travelers posted a major earnings beat Thursday, breaks out. Marsh McLennan eyes buy point after results.

Investors Business Daily

What to Expect From Marsh & Mclennan's Next Quarterly Earnings Report

Marsh & McLennan is expected to release its third-quarter earnings this month, and analysts project a single-digit profit increase.

Barchart

Marsh & McLennan Companies Stock: Is MMC Underperforming the Financial Sector?

Marsh & McLennan Companies has underperformed the financial sector over the past year, and analysts remain cautious about the stock’s prospects.

Barchart

Is Marsh & McLennan Stock Outperforming the Dow?

Despite Marsh & McLennan outperforming the Dow Jones Industrial Average, Wall Street analysts hold a neutral stance on the stock’s prospects.

Barchart

AI-Powered Misinformation Is The World's Biggest Short-Term Threat, Claims New Report

With 2024 being dubbed by many as "the year of elections", their Global Risks Report expressed fears that a wave of artificial intelligence-driven misinformation and disinformation could influence democratic processes and polarise society.

International Business Times UK

World Economic Forum Warns of AI-Driven Misinformation Threatening Global Stability and Elections

The WEF's annual risks report, based on insights from 1,400 experts, has unveiled a chilling reality, stating that 30 per cent of respondents foresee a high probability of a global catastrophe within the next two years.

International Business Times UK

How Marsh McLennan gets employees to use their well-being benefits through an app

Marsh McLennan employees can access tailored well-being recommendations, through an app, based on their individual needs.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Insurance Broker Giant, IBD Stock Of The Day, Defies S&P 500 Pullback, Builds Possible Base

MMC stock has gained more than 16% in 2023.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022

Upgrades

Benzinga

Insurance Stocks Moving In Thursday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

Here's How Much You Would Have Made Owning Marsh & McLennan Stock In The Last 15 Years

Marsh & McLennan (NYSE:MMC) has outperformed the market over the past 15 years by 4.99% on an annualized basis producing an average annual return of 11.19%. Currently, Marsh & McLennan has a market capitalization of $77.50 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Looking Into Marsh & McLennan's Recent Short Interest

Marsh & McLennan's (NYSE:MMC) short percent of float has risen 23.61% since its last report. The company recently reported that it has 4.45 million shares sold short, which is 0.89% of all regular shares that are available for trading.

Benzinga

Here's How Much You Would Have Made Owning Marsh & McLennan Stock In The Last 10 Years

Marsh & McLennan (NYSE:MMC) has outperformed the market over the past 10 years by 6.09% on an annualized basis producing an average annual return of 16.75%. Currently, Marsh & McLennan has a market capitalization of $73.88 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022

Benzinga

Analyst Ratings for Marsh & McLennan

Over the past 3 months, 8 analysts have published their opinion on Marsh & McLennan (NYSE:MMC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

Benzinga

Analyst Ratings for Marsh & McLennan

Within the last quarter, Marsh & McLennan (NYSE:MMC) has observed the following analyst ratings:

Benzinga

$100 Invested Marsh & McLennan Stock 5 Years Ago Would Be Worth This Much

Marsh & McLennan (NYSE:MMC) has outperformed the market over the past 5 years by 6.21% on an annualized basis producing an average annual return of 18.7%. Currently, Marsh & McLennan has a market capitalization of $86.60 billion.

1 2

People

Rishi Sunak

22,204 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Insurance

6,946 stories

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.